Oesterle T, Bhanuprakash K, Risma C, et al. Substance use disorders and telehealth in the COVID-19 pandemic era: A new outlook. Mayo Clinic Proceedings. 2020;95(12):2709-2718.

Article  CAS  PubMed  Google Scholar 

Cantor J, McBain R, Kofner A, et al. Telehealth adoption by mental health and substance use disorder treatment facilities in the COVID-19 pandemic. Psychiatric Services. 2021;73(4):411-417.

Article  PubMed  Google Scholar 

Hilty D, Gentry M, McKean A, et al. Telehealth for rural diverse populations: Telebehavioral and cultural competencies, clinical outcomes and administrative approaches. mHealth. 2020;6(20):1–19.

Hughes P, Verrastro G, Fusco C, et al. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic. The Journal of Rural Health. 2021;37(3):467-472.

Article  PubMed  PubMed Central  Google Scholar 

Jones C, Shoff C, Hodges K, et al. Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(10):981-992.

Article  PubMed  PubMed Central  Google Scholar 

Ngo Q, Braughton J, Gliske K, et al. In-person versus telehealth setting for delivery of substance use disorder treatment: Ecologically valid comparison study. JMIR Formative Research. 2022;6(4):e34408.

Article  PubMed  PubMed Central  Google Scholar 

Lin L, Casteel D, Shigekawa E, et al. Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. Journal of Substance Abuse Treatment. 2019;101:38-49.

Article  PubMed  Google Scholar 

Qeadan F, Shimizu S, Tingey B, et al. The impact of increased telehealth use on the treatment of substance use disorder during the COVID-19 pandemic. SSM - Population Health. 2025;30:101780.

Article  PubMed  PubMed Central  Google Scholar 

Vakkalanka J, Lund B, Ward M, et al. Telehealth utilization is associated with lower risk of discontinuation of buprenorphine: A retrospective cohort study of US veterans. Journal of General Internal Medicine. 2022;37:1610-1618.

Article  PubMed  Google Scholar 

McCord C, Ullrich R, Merchant K, et al. Comparison of in-person vs. telebehavioral health outcomes from rural populations across America. BMC Psychiatry. 2022;22(778):1–9.

Bulkes N, Davis K, Kay B, et al. Comparing efficacy of telehealth to in-person mental health care in intensive-treatment-seeking adults. Journal of Psychiatric Research. 2022;145:347-352.

Article  PubMed  Google Scholar 

Marcin J, Shaikh U, Steinhorn R. Addressing health disparities in rural communities using telehealth. Pediatric Research. 2016;79:169-176.

Article  PubMed  Google Scholar 

Pro G, Fairman B, Baloh J, et al. Temporal trends in telehealth availability in mental health treatment settings: Differences in growth by state urbanicity and rurality, 2015-2020. Journal of Urban Health. 2023;100(6):1149-1158.

Article  PubMed  PubMed Central  Google Scholar 

Patel S, Huskamp H, Busch A, et al. Telemental health and US rural-urban differences in specialty mental health use, 2010-2017. American Journal of Public Health. 2020;110(9):1308-1314.

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Amaize A, Barath D. Evaluating telehealth adoption and related barriers among hospitals located in rural and urban areas. The Journal of Rural Health. 2020;37(4):801-811.

Article  PubMed  PubMed Central  Google Scholar 

Tauscher J, DePue M, Swank J, et al. Determinants of preference for telehealth versus in-person treatment for substance use disorders: A discrete choice experiment. Journal of Substance Use and Addiction Treatment. 2023;146:208938.

Article  CAS  PubMed  Google Scholar 

Parsons E, Figueroa Z, Kiserodt M, et al. Relative preference for in-person, telehealth, digital, and pharmacologic mental health care after the COVID-19 pandemic: Cross-sectional questionnaire study. Journal of Medical Internet Research. 2025;27:e54608.

Article  PubMed  PubMed Central  Google Scholar 

Honey A, Hines M, Barton R, et al. Preferences for telehealth: A qualittive study with people accessing a new mental health service. Digital Health. 2023;9:1-13.

Article  Google Scholar 

Ebbert J, Ramar P, Tulledge-Scheitel S, et al. Patient preferences for telehealth services in a large multispecialty practice. Journal of Telemedicine and Telecare. 2021;29(4):298-303.

Article  PubMed  Google Scholar 

Cao Y, Chen D, Smith M. Use telehealth as needed: Telehealth substitutes in-person primary care and associates with the changes in unplanned events and follow-up visits. BMC Health Services Research. 2023;23(426):1-10.

Google Scholar 

Sugarman D, Busch A, McHugh R, et al. Patients’ perceptions of telehealth services for outpatient treatment of substance use disorder during the COVID-19 pandemic. American Journal of Addiction. 2021;30(5):445-452.

Article  Google Scholar 

Walker L, Cui M, Cantor J, et al. Disparities in substance use disorder telehealth services. JAMA Network Open. 2025;8(2):e2459606.

Article  PubMed  PubMed Central  Google Scholar 

Iasiello J, Rajan A, Zervos E, et al. Racial differences in patient-reported access to telehealth: An important and unmeasured social determinant of health. Oncology Practice. 2023;19(12):1215-1225.

PubMed  Google Scholar 

Hughto J, Peterson L, Perry N, et al. The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19. Journal of Substance Abuse Treatment. 2021;120:108163.

Article  CAS  PubMed  Google Scholar 

Timlinson M, McCann-Pineo M, Thomas M, et al. Demographic differences in services utilization across in-person (2019), telehealth (2020), and hybrid (2021) outpatient substance use services in New York. Journal of Substance Use and Addiction Treatment. 2023;150:209047.

Article  Google Scholar 

Faysal J, Noor-E-Alam M, et al. Impact of telehealth, in-person, and hybrid care modalities on buprenorphine discontinuation among patients with opioid use disorder: A retrospective cohort study on commercially insured individuals. SSRN. 2025;Online ahead of print, February 4, 2025.

Cantor J, DeYoreo M, Hanson R, et al. Patterns in geographic distribution of substance use disorder treatment facilities in the US and accepted forms of payment from 2010 to 2021. JAMA Network Open. 2022;5(11):e2241128.

Article  PubMed  PubMed Central  Google Scholar 

Pro G, Brown C, Johnson O, et al. Comprehensive and integrated services in specialty mental health treatment facilities in the US: Differences by the racial/ethnic composition of the facility’s clientele, 2020. Community Mental Health Journal. 2023;Published online ahead of print on July 12, 2023.

Cummings J, Wen H, Ko M, et al. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States. JAMA Psychiatry. 2014;71(2):190-196.

Article  PubMed  PubMed Central  Google Scholar 

Mitchell P, Curtin K, Magliocca N. Race, rurality and geographic accessibility to medication for opioid use disorder in the U.S. Journal of Maps. 2023;19(1):1–13.

Mitchell P, Samsel S, Curtin K, et al. Geographic disparities in access to medication for opioid use disorder across US census tracts based on treatment utilization behavior. Social Science & Medicine. 2022;302:114992.

Article  Google Scholar 

Pro G, Neighbors H, Wilkerson B, et al. Place-based access to integrated mental health services within substance use disorder treatment facilities in the US. Social Science & Medicine. 2025;369:117843.

Article  Google Scholar 

Centers for Disease Control and Prevention. CDC Social Vulnerability Index. Centers for Disease Control and Prevention Agency for Toxic Substances and Disease Registry Place and Health. 2021.

Gibbons R, Olfson M, Saulsberry L, et al. Social vulnerability and prevalence and treatment for mental health and substance use disorders. JAMA Psychiatry. 2024;81(10):976-984.

Article  PubMed  PubMed Central  Google Scholar 

Stokes E, Pickens C, Wilt G, et al. County-level social vulnerability and nonfatal drug overdose emergency department visits and hospitalizations, January 2018 - December 2020. Drug and Alcohol Dependence. 2023;247:109889.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Archambault J, Nastasi V. State Policy Agenda for Telehealth Innovation - 2023 Update. The Cicero Institute, The Pioneer Instutute, and the Reason Foundation. February, 2023. Sourced from: <https://reason.org/policy-brief/state-policy-agenda-for-telehealth-innovation/>. Accessed 19 Apr 2025.

Pro G, Brown C, Hayes C, et al. Trends in telehealth availability among specialty mental health treatment facilities in the US, 2015–2019: Differences by state telehealth policies. Oral presentation presented at the American Public Health Association Annual Meeting. November 8, 2022. Mental Health Section. Session: Novel Aproaches to Public Mental Health Policy and Practice. Session Number 4150.

Agniel D, Cantor J, Golan O, et al. How are state telehealth policies associated with services by substance use disorder treatment facilities? Evidence from 2019-2022. Drug and Alcohol Dependence. 2023;252:110959.

Article  PubMed  PubMed Central  Google Scholar 

Link B, Phelan J. Social conditions as fundamental causes of disease. Journal of Health and Social Behavior. 1995;Spec No:80–94.

Phelan J, Link B, Tehranifar P. Social conditions as fundamental causes of health inequalities: Theory, evidence, and policy implications. Journal of Health and Social Behavior. 2010;51:S28-S40.

Article  PubMed  Google Scholar 

Substance Abuse and Mental He